History | Romosozumab for treating severe osteoporosis | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 141 KB)

Published:

25 May 2022

Final draft guidance

Final draft guidance
Final appraisal document (PDF 288 KB)

Published:

01 April 2022

Draft guidance: 1

Draft guidance: 1
Appraisal consultation document (online commenting)
Appraisal consultation document (PDF version) (PDF 281 KB)

Published:

25 November 2021
Public committee slides (PDF 1.82 MB)

Published:

25 November 2021
Committee papers (PDF 4.6 MB)

Published:

25 November 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 206 KB)

Published:

23 March 2021
Draft matrix post referral (PDF 185 KB)

Published:

23 March 2021

Invitation to participate

Equality impact assessment (Scoping) (PDF 128 KB)

Published:

20 April 2021
Final stakeholder list (PDF 186 KB)

Published:

20 April 2021
Final scope (PDF 198 KB)

Published:

20 April 2021
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 556 KB)

Published:

20 April 2021